P-D 537 P-D 537 (Celontin kapseals 150 MG)
Generic Name: methsuximide
Pill imprint P-D 537 P-D 537 has been identified as Celontin kapseals 150 MG.
Celontin is used in the treatment of seizures and belongs to the drug class succinimide anticonvulsants. FDA has not classified the drug for risk during pregnancy. Celontin 150 MG is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- methsuximide
- Imprint:
- P-D 537 P-D 537
- Strength:
- 150 MG
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Succinimide anticonvulsants
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
More about Celontin (methsuximide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: succinimide anticonvulsants
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
